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Two populations of coated vesicles, different in size, have been isolated from the bovine adrenal cortex. 
The enrichment of the LDL receptor from the plasma membrane to the large coated vesicles and then to 
the small ones was evidenced by ligand-blotting ELISA assays. The LDL receptor has been characterized 
as a 130-kDa proteic component which retains the binding specificity and structural features in plasma 
membranes as well as in the two classes of coated vesicles. 
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1. INTRODUCTION 
In adrenocortical cells, biosynthesis of cor- 
ticosteroid hormones requires unesterified 
cholesterol provided by LDL, the major 
cholesterol-carrying lipoprotein in human plasma, 
internalized via receptor-mediated endocytosis 
(RME) [l]. Internalization is initiated by interac- 
tion with the specific high-activity LDL membrane 
receptor clustered in coated pits (CP), which on 
their cytoplasmic side are characterized by a lattice 
of clathrin [2]. Coated vesicles involved in the in- 
ternalization and recycling process are mor- 
phologically different [3,4]. According to Ander- 
son et al. [5], the large coated vesicles (LCV) which 
derive from pinching off of CP participate in the 
endocytic transport of the LDL-receptor complex 
to lysosomes. There, unesterified cholesterol is 
Abbreviations: LDL, low density lipoprotein; ELISA, 
enzyme-linked immunosorbent assay; BSA, bovine 
serum albumin; NC, nitrocellulose paper; Mes, 2-(N- 
morpholino)ethanesulfonic acid; SDS-PAGE, SDS- 
polyacrylamide gel electrophoresis 
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liberated, and further, converted to corticosteroid 
hormones in other organelles. Small coated 
vesicles (XV) are involved in the receptor recycl- 
ing. In this cyclic process, the LDL receptor par- 
ticipates in the regulation of the cholesterol evel in 
adrenocortical cells [6]. Therefore, characteriza- 
tion of the LDL receptor at different steps of this 
cyclic process appears important in the under- 
standing of the regulation mechanism. 
Identification of the LDL receptor as a 
glycoprotein of 160 kDa under reducing condi- 
tions and 130 kDa under mild non-reducing condi- 
tions has been made with the purified receptor or 
with plasma membrane preparations [7]. In these 
membranes the LDL receptor is topologically 
heterogeneous, i.e., mainly concentrated in CP 
which represent only 2% of the plasma membrane 
surface [1,2] and randomly redistributed by the 
recycling process. 
Here, for the first time, two populations of 
coated vesicles, LCV and SCV, have been isolated, 
uniform in composition and morphologically 
highly homogeneous. Ligand-blotting ELISA 
assays have allowed demonstration of not only the 
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presence of the LDL receptor in LCV and SCV but 
also an LDL receptor enrichment in these coated 
vesicles as compared to its concentration in partial- 
ly purified plasma membrane extracts. 
The binding specificity and the apparent M, of 
the LDL receptor observed with the 3 fractions 
studied are in agreement with previously reported 
results achieved under similar experimental 
conditions. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Suramin (germanin) was the Bayer 205 product. 
Triton X-100, amido black lOB, and BSA (fraction 
V) were Sigma products. SDS was a BDH product. 
All other chemicals were analytical grade Merck 
products. LDL and rabbit LDL antibodies were 
bar: 100nm 
Fig.1. Electron micrographs of LCV and SCV. 
Separation was obtained by a discontinuous D20 
sucrose gradient. Bars: 100 nm. 
kindly provided by M. Ayrault-Jarrier. Goat anti- 
rabbit IgG horseradish peroxidase conjugate was 
obtained from Pasteur Production. 3,3 ‘-Diamino- 
benzidine tetrahydrochloride was from Interchim. 
NC (0.45 pm pore size) was from Biorad. 
2.2. Adrenal membrane preparation 
The extraction step giving the crude membrane 
fractions was carried out as described by Schlegel 
and Schwyzer [8]. This fraction was layered on top 
of a sucrose density discontinuous gradient (15, 19, 
22.5, 26, 35, 45, 50%; w/w) and centrifuged at 
90000 x g for 1.5 h. The membranes were col- 
lected at the 22.5-26% interface and extensively 
dialysed against 1 mM NaHCOs, pH 7.4. 
2.3. Coated vesicles 
These were purified according to Nandi et al. [9] 
with a modification in the gradient step. The crude 
vesicles were layered on top of a D20 sucrose 
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Fig.2. SDS-PAGE electrophoresis of LCV and SCV. 
Coomassie blue staining. 
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discontinuous gradient (0, 8, 12, 16, 24%) and cen- 
trifuged at 90000 x g for 1.5 h in a swinging rotor. 
SCV were collected at the 12-16% interface and 
LCV at the 16-24% interface. Fractions were 
dialyzed against Mes buffer, pH 6.5. 
2.6. SDS-PAGE 
0.1% SDS-PAGE was performed in 7.5% 
polyacrylamide slab gels according to Laemmli 
Ill] with or without a reducing agent (,& 
mercaptoethanol). A high-M, kit (Sigma) was used 
for Mr calibration. 
2.4. Proteins 
The protein content of samples was determined 
by the method of Petterson [lo]. 2.7. Immunoblotting 
2.5. Electron microscopy 
A drop of material was placed on a 200 mesh 
Formwar carbon-coated grid and allowed to air- 
dry. Samples were negatively stained with 2% 
uranyl acetate. Micrographs were taken on a Jeol 
100 CX electron microscope. 
Proteins were transferred from SDS-PAGE to 
NC paper according to Towbin et al. [12]. The NC 
paper was incubated with the ligand. A second in- 
cubation after washing was performed with rabbit 
LDL antibodies. The bound antibodies were 
detected by ELISA using peroxidase-labeled goat 
anti-rabbit IgG. 
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Fig.3. Quantitative estimation by ligand-blotting ELISA of the LDL receptor binding in plasma membranes, XV and 
LCV. Each fraction was subjected to 7.5% SDS-PAGE and transferred to NC paper. (1) Plasma membranes (140pg 
protein), (2) LCV (70 pug protein), (3) SCV (70 pg protein). Lane A (l-3) was stained with amido black 10B. Lanes B-F 
were incubated with human LDL at the concentrations given below each lane, followed by ELISA detection. 
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3. RESULTS AND DISCUSSION 
Two populations of coated vesicles have been 
isolated from bovine adrenal cortex using the 
modified DzO sucrose discontinuous gradient 
described above. As shown by the electron 
micrographs (fig. l), these two populations have 
different sizes corresponding to differences in den- 
sity as revealed by the gradient: LCV have a densi- 
ty range of 1.18-1.21, with diameters from 90 to 
120 nm; SCV, a density range of 1.16-1.i7 and 
diameters from 50 to 80 nm. 
The major protein components analyzed by 
Coomassie blue stained SDS-PAGE (fig.2) are the 
same in LCV and SCV and as those previously 
described in the mixture of coated vesicles from 
adrenal cortex and other tissues [13]. However, a 
A B 
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difference in the staining intensity appears between 
the respective components of SCV and LCV. 
Moreover, two high molecular mass species, 210 
and 230 kDa, seem to be characteristic of LCV. 
These components could belong to the lipoprotein 
peptides as suggested by a comparison with SDS- 
PAGE of LDL under denaturing conditions [ 141. 
Such a hypothesis would be consistent with the en- 
docytic function recognized in situ for the LCV [3] 
and is furthermore supported by the absence of 
these components in the SCV (fig.2). A relatively 
high proportion of the isolated SCV (80%) as com- 
pared with the low one of LCV (20%) suggests a 
plasma membrane origin for LCV which are 
known to have a transient lifetime and to disap- 
pear in a time range of a minute [2] by losing their 
clathrin coat. 
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Fig.4. Visualization of LDL receptor in plasma membrane, LCV and SCV by ligand-blotting ELISA. Each fraction was 
subjected to 7.5% SDS-PAGE and transferred to NC. (1) Plasma membranes (140,q protein), (2) LCV (70pg protein), 
(3) SCV (70 fig protein). The NC strips were incubated with, respectively: lane A (l-3), 4.5 pg protein/ml of human 
LDL; lane B (l-3), 4.5 gg protein/ml of human LDL f 7.5 mM Suramin; lane C (l-3), 4.5 pg protein/ml of human 
LDL + 10 mM EDTA; lane D, only 20 fig protein/lane, same conditions as A. Binding of LDL was detected by ELISA. 
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The presence of the LDL receptor and its activi- 
ty have been determined qualitatively and 
estimated quantitatively in the plasma membrane 
and in the LCV and SCV. The ligand-blotting 
ELISA method has been used for the study of 
plasma membranes, LCV and SCV. The limit of 
detection was 20 ,ug total protein, in coated vesicles 
layered on SDS-PAGE, an amount insufficient to 
be revealed by Coomassie blue staining. Thus we 
have been able to characterize a component which 
binds LDL in a specific way and is present in all 3 
preparations. This receptor with an apparent 
molecular mass (in the absence of reducing agent) 
of -130 kDa binds LDL in increasing amounts 
(fig.3) between 0.045 and 4.4pg/ml protein and 
reaches saturation at higher concentrations as seen 
by visual inspection. Inhibition of LDL binding by 
Suramin or EDTA was observed (fig.4) indicating 
the specificity of the LDL receptor for its ligand. 
These results fit in with the data obtained with 
the affinity-purified LDL receptor from adrenal 
cortex membranes [ 15-171 and with the LDL 
receptor in crude plasma extracts visualized by im- 
muno or ligand blotting [18,19]. This report 
demonstrates for the first time the presence of the 
LDL receptor in coated vesicles by the ligand- 
blotting technique. 
It is worth noting that isolation of LCV and 
SCV has allowed the demonstration of a higher 
amount of LDL receptor in SCV than in LCV (figs 
3-5) and a higher amount in both types of coated 
vesicles as compared with the plasma membranes. 
The binding specificity and structural characteris- 
tics (130 kDa) of the LDL receptor, preserved in 
all fractions studied (plasma membranes, LCV, 
SCV) under the experimental conditions of SDS- 
PAGE and ligand blotting, indicate that the recep- 
tor remains unchanged in these different cell or- 
ganelles. The origin of the SCV remains to be 
determined before assigning a specific biological 
role to this class in the LDL receptor cycle. 
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